Drug Dosage CalculationsDrug MonitoringArea Under CurveDrug InteractionsDose-Response Relationship, DrugDrug Administration ScheduleTreatment OutcomeAdministration, OralMetabolic Clearance RateWarfarinInternational Normalized RatioSocial AdjustmentRenal InsufficiencyAnticoagulantsDrug Therapy, CombinationRitonavirProspective StudiesDrug Therapy, Computer-AssistedTime FactorsTriazolesHIV Protease InhibitorsKidney Function TestsDrug Utilization ReviewInfusions, IntravenousImmunosuppressive AgentsBiological AvailabilityHalf-LifeCross-Over StudiesBenzoxazinesBusulfanRisk AdjustmentMethotrexateRetrospective StudiesAnti-HIV AgentsDouble-Blind MethodFollow-Up StudiesThiophenesLopinavirInfusions, ParenteralCytochrome P-450 CYP3ACreatinineCyclosporineKidney DiseasesAdjustment DisordersGlomerular Filtration RatePharmaceutical PreparationsAntimetabolites, AntineoplasticInjections, IntravenousRisk FactorsReverse Transcriptase InhibitorsAntineoplastic AgentsAntirheumatic AgentsModels, BiologicalAge FactorsHIV InfectionsPractice Guidelines as TopicAntifungal AgentsAntineoplastic Combined Chemotherapy ProtocolsPyrimidinesDiabetes Mellitus, Type 1NeoplasmsHypoglycemic AgentsBody WeightSurvival AnalysisFluorouracilChromatography, High Pressure LiquidCohort StudiesPregnancyArthritis, RheumatoidPyridinesRecurrenceAdaptation, PsychologicalRadiation DosageLethal Dose 50Cross-Sectional StudiesOdds RatioUnited StatesRegression AnalysisCase-Control StudiesLogistic ModelsRadiometryProportional Hazards ModelsQuestionnairesMultivariate AnalysisLongitudinal StudiesIncidenceRisk AssessmentSex FactorsLinear ModelsBody Mass IndexBiological MarkersDose-Response Relationship, RadiationAnalysis of VarianceRadiotherapy DosagePrevalenceRiskDose FractionationSmokingCardiovascular DiseasesConfidence Intervals